LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Adoption of New Digital Pathology PACS to Improve Cancer Care for Patients in Sweden

By LabMedica International staff writers
Posted on 11 Nov 2015
Print article
Image: Sectra Digital Pathology Solution (Photo courtesy of Sectra).
Image: Sectra Digital Pathology Solution (Photo courtesy of Sectra).
Physicians at the Linköping University Hospital are rolling out a new Internet Technology (IT) solution for the Pathology Department, after completing testing of the system.

The Linköping University Hospital (Linköping, Sweden) serves the Östergötland Swedish healthcare Region and has one the first digital pathology departments in the country. The new system will enable digital review of pathology exams by all 20 pathologists working in the hospital.

The digital pathology Picture Archive and Communications System (PACS) was provided by Sectra (Linköping, Sweden) and will store digital pathology images. The system will enable pathologists and clinicians to improve cancer care by speeding up access to, and sharing of pathology images needed for review, diagnosis, and treatment.

The new Sectra pathology image storage solution will provide pathologists with central storage of pathology images and new tools to support diagnoses and improve review results. Pathologists will have access to images when they need them, for review with all experts, including radiologists and pathologists, involved in the cancer care treatment cycle.

The digital pathology solution uses the same infrastructure as Sectra’s radiology PACS, which is also installed in the Region Östergötland hospital, in the radiology department. This facilitates integrated diagnostics, such as multidisciplinary hospital rounds, and reduces hospital operating, and maintenance costs.

Anna Bodén, Consultant histopathologist at Linköping University Hospital, said, “I read all of my cases digitally and feel very confident about it. Sectra’s solution is fast, easy to use and very stable, which is necessary because we review large volumes and fast answers are decisive for effective cancer care.”

Related Links:

Sectra
Linköping University Hospital


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more